Milestone initiates U.S. participation in pivotal clinical trial of the i-Lumen AMD System for patients with intermediate to advanced dry age-related macular degenerationBLOOMINGTON, Minn., ...
PRNewswire/ -- i-Lumen Scientific, Inc., a clinical-stage medical technology company developing bioelectric therapies for ...
"At-home microcurrent devices can be a beneficial part of your skin care routine, but they work best for mild improvements ...
Our beauty editor’s favorite microcurrent device just hit its lowest price ever for Prime Day. Save 30% on the NuFace Trinity+ Starter Kit. Don’t wait to shop—Prime Day ends June 26. “This NuFace ...
Cell replacement therapy is currently being investigated to restore the retinal pigment epithelium (RPE) layer and treat vision decline due to dry age-related macular degeneration (AMD). The Neural ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Rory Evans Rory Evans is a writer focused on skin-care and beauty products.
IDE approval by the FDA expands global trial to the United States as first study participant is treated in the United Kingdom BLOOMINGTON, Minn., March 31, 2026 /PRNewswire/ -- i-Lumen Scientific, Inc ...
Every day tech, like your smartphone or computer, can help manage wet AMD through built-in accessibility features such as voice commands, screen magnification, and high-contrast settings.
Over 24 months, patients with dry age‑related macular degeneration (AMD) who received light therapy with three wavelengths gained clarity of vision, had a reduced incidence of new geographic atrophy, ...
AMD has been selling “Ryzen AI”-branded laptop processors for around a year and a half at this point. In addition to including modern CPU and GPU architectures, these are attempting to capitalize on ...
Julie Rosenthal, MD, MS, discusses signs and symptoms of age-related macular degeneration as well as methods of treatment. Rosenthal: Some people don't have any symptoms at all when the disease is ...